NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 261 filers reported holding NATERA INC in Q2 2022. The put-call ratio across all filers is 1.30 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,425,000 | -9.1% | 100,000 | 0.0% | 0.03% | -7.1% |
| Q2 2023 | $4,866,000 | -12.4% | 100,000 | 0.0% | 0.03% | -6.7% |
| Q1 2023 | $5,552,000 | +38.2% | 100,000 | 0.0% | 0.03% | +25.0% |
| Q4 2022 | $4,017,000 | -8.3% | 100,000 | 0.0% | 0.02% | -17.2% |
| Q3 2022 | $4,382,000 | +23.6% | 100,000 | 0.0% | 0.03% | +45.0% |
| Q2 2022 | $3,544,000 | -17.7% | 100,000 | -56.3% | 0.02% | -37.5% |
| Q2 2018 | $4,304,000 | +103.0% | 228,676 | 0.0% | 0.03% | +77.8% |
| Q1 2018 | $2,120,000 | +3.1% | 228,676 | 0.0% | 0.02% | 0.0% |
| Q4 2017 | $2,056,000 | -30.3% | 228,676 | 0.0% | 0.02% | -25.0% |
| Q3 2017 | $2,948,000 | +18.7% | 228,676 | 0.0% | 0.02% | +9.1% |
| Q2 2017 | $2,483,000 | +22.4% | 228,676 | 0.0% | 0.02% | +29.4% |
| Q1 2017 | $2,028,000 | -30.5% | 228,676 | -8.3% | 0.02% | -41.4% |
| Q4 2016 | $2,919,000 | -41.6% | 249,269 | -44.6% | 0.03% | -35.6% |
| Q3 2016 | $5,000,000 | -7.9% | 450,000 | 0.0% | 0.04% | -21.1% |
| Q2 2016 | $5,429,000 | +26.7% | 450,000 | 0.0% | 0.06% | +26.7% |
| Q1 2016 | $4,284,000 | +58.7% | 450,000 | +80.0% | 0.04% | +104.5% |
| Q4 2015 | $2,700,000 | -0.5% | 250,000 | 0.0% | 0.02% | -12.0% |
| Q3 2015 | $2,713,000 | – | 250,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |